Danny.
You can not be serious.This is the best biotech deal completed for the last 10 years .Not only the potential deal is us $335 million (approx$370 million aussie).The royalty stream at 20% is seriously big .Asuming axiron sell product for $500 million per year the royalty stream for acr is 100 million per year not a bad annuity i would have to say.Lets get the poorly informed sellers from bailleaus out the way and off to the races we go.
Danny.You can not be serious.This is the best biotech deal...
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.4¢ |
Change
0.001(1.59%) |
Mkt cap ! $18.60M | |||
| Open | High | Low | Value | Volume |
| 6.4¢ | 6.6¢ | 6.3¢ | $27.96K | 432.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3828 | 6.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.4¢ | 214977 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.3¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 6.5¢ | 6.7¢ | 6.3¢ | 79044 | ||
| Last updated 15.56pm 10/05/2024 ? | |||||
| ACR (ASX) Chart |